General description
INN
Diazoxide
Medicine type
Chemical agent
EML status history
First added in 2019
(TRS
1021)
for
Persistent hyperinsulinemic hypoglycaemia of infancy
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Medicines for hypoglycaemia
- Oral > Liquid: 50 mg per mL
- Oral > Solid: 50 mg